Hematology Weekly News - June 9th 2025
🔬🩸 Hematology Updates: Myeloma Advances, Menin Inhibitor Momentum, and Orphan…
Hematology Weekly News - May 26th 2025
🔬🩸 Hematology Updates: Blenrep Combinations, CAR-T Breakthroughs, and Global…
Hematology Weekly News - May 19th 2025
🔬🩸 Hematology Updates: CAR-T Milestones, Myeloma Breakthroughs, and Global…
Hematology Weekly News - May 12th 2025
🔬🩸 Hematology Updates: Myeloma Fast Track, CAR-T Population Impact, and New…
Hematology Weekly News - April 28th 2025
🩸 Hematology Headlines You Shouldn’t Miss This Week: Major Approvals,…
Hematology Weekly News - April 14th 2025
🩸 Hematology Headlines You Shouldn’t Miss This Week Welcome to this week’s…
Hematology Weekly News - March 17th 2025
🚀 Hematology News: Advancements in blood cancers, acute and chronic leukemias,…
Hematology Weekly News - March 3rd 2025
🔬 Groundbreaking Advances in Hematology: AML, CML, CLL, multiple myeloma,…
Hematology Weekly News - February 17th 2025
🔬 Hematology & Blood Cancer Updates: Weekly Clinical Research & FDA…
How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
The Challenge: Understanding how KOLs define the treatment evolution and the…
How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
The Challenge: Understanding how KOLs define the treatment evolution and the…
Multiple myeloma treatment: Why we still need novel scientific research.
Multiple myeloma (MM) is an incurable form of hematological cancer affecting…
